← Back
$LYRA All transactions

Lyra Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$6K

Shares

684

Price

$9

Filed

Jul 14

Insider

Name

Cavalier Jason

Title

Chief Financial Officer

CIK

0001883290

Roles

Officer

Transaction Details

Transaction Date

2025-07-10

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

519,316

Footnotes

Shares were sold to cover taxes upon the vesting of restricted stock units ("RSUs") pursuant to a mandatory Rule 10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Filing Info

Accession No.

0000950170-25-095681

Form Type

4

Issuer CIK

0001327273

Cavalier Jason's History

Date Ticker Type Value
2026-04-01 LYRA D $0
2026-01-06 LYRA $3K
2025-07-10 LYRA $6K

Other Insiders at LYRA (90d)

Insider Bought Sold Last
Palasis Maria
Principal Executive Officer
2026-04-01
Cavalier Jason
Principal Financial Officer
2026-04-01